Date: 2018-01-18
Type of information: Nomination
Compound: vice president business development
Company: Alligator Bioscience (Sweden)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On January 18, 2018, Alligator Bioscience announced the appointment of Anu Balendran as Vice President Business Development. Dr Balendran will be responsible for leading Alligator’s preclinical projects towards out-licensing. He has a PhD in Biochemistry and will join Alligator from his current role as External Innovation Director, AstraZeneca. He will assume his new role on 1 May 2018.
- This appointment follows those of Charlotte A Russell, MD, PhD, as Chief Medical Officer and Peter Ellmark, PhD, Associate Professor, as Vice President Discovery, in December 2017, as Alligator prepares a number of drug candidates for clinical studies, partnerships and licensing deals.
Financial terms:
Latest news:
Is general: Yes
